|
Oncogenes and Tumor Suppressors
Citations 251-260 of 795 total displayed.
|
Past content
(since May 2000):
|
Bcr-Abl reduces endoplasmic reticulum releasable calcium levels by a Bcl-2–independent mechanism and inhibits calcium-dependent apoptotic signaling
- Katarzyna Piwocka, Susanne Vejda, Thomas G. Cotter, Gerald C. O'Sullivan, and Sharon L. McKenna
Blood 2006; 107: 4003-4010.
[Abstract]
[Full text]
[PDF]
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
- Christian Thiede, Sina Koch, Eva Creutzig, Christine Steudel, Thomas Illmer, Markus Schaich, and Gerhard Ehninger, for the Deutsche Studieninitiative Leukämie (DSIL)
Blood 2006; 107: 4011-4020.
[Abstract]
[Full text]
[PDF]
The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells
- Suzanne Trudel, A. Keith Stewart, Eran Rom, Ellen Wei, Zhi Hua Li, Sarit Kotzer, Irina Chumakov, Yossi Singer, Hong Chang, Sheng-Ben Liang, and Avner Yayon
Blood 2006; 107: 4039-4046.
[Abstract]
[Full text]
[PDF]
The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)–like disease
- Yoshiyuki Yamada, Marc E. Rothenberg, Andrew W. Lee, Hiroko Saito Akei, Eric B. Brandt, David A. Williams, and Jose A. Cancelas
Blood 2006; 107: 4071-4079.
[Abstract]
[Full text]
[PDF]
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells
- Clara Guerzoni, Michela Bardini, Samanta A. Mariani, Giovanna Ferrari-Amorotti, Paolo Neviani, Maria Luisa Panno, Ying Zhang, Robert Martinez, Danilo Perrotti, and Bruno Calabretta
Blood 2006; 107: 4080-4089.
[Abstract]
[Full text]
[PDF]
Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas
- Wayne Tam, Mario Gomez, Amy Chadburn, Joong W. Lee, Wing C. Chan, and Daniel M. Knowles
Blood 2006; 107: 4090-4100.
[Abstract]
[Full text]
[PDF]
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells
- Llorenç Coll-Mulet, Daniel Iglesias-Serret, Antonio F. Santidrián, Ana M. Cosialls, Mercè de Frias, Esther Castaño, Clara Campàs, Montserrat Barragán, Alberto Fernández de Sevilla, Alicia Domingo, Lyubomir T. Vassilev, Gabriel Pons, and Joan Gil
Blood 2006; 107: 4109-4114.
[Abstract]
[Full text]
[PDF]
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)
- Paola Secchiero, Elisa Barbarotto, Mario Tiribelli, Carlotta Zerbinati, Maria Grazia di Iasio, Arianna Gonelli, Francesco Cavazzini, Diana Campioni, Renato Fanin, Antonio Cuneo, and Giorgio Zauli
Blood 2006; 107: 4122-4129.
[Abstract]
[Full text]
[PDF]
SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling
- Jean-François Honorat, Ashraf Ragab, Laurence Lamant, Georges Delsol, and Jeannie Ragab-Thomas
Blood 2006; 107: 4130-4138.
[Abstract]
[Full text]
[PDF]
X-inactivation–based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis
- Ross L. Levine, Claude Belisle, Martha Wadleigh, David Zahrieh, Stephanie Lee, Pierre Chagnon, D. Gary Gilliland, and Lambert Busque
Blood 2006; 107: 4139-4141.
[Abstract]
[Full text]
[PDF]
|
|
